We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$463M
AUM Growth
+$88.4M
Cap. Flow
+$76.3M
Cap. Flow %
16.48%
Top 10 Hldgs %
15.82%
Holding
310
New
106
Increased
69
Reduced
87
Closed
41

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$5.74M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.51M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.03M
4
IMPV
Imperva, Inc.
IMPV
+$4.56M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.3M

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$4.9M
2
TSCO icon
Tractor Supply
TSCO
+$4.44M
3
LPNT
LifePoint Health, Inc.
LPNT
+$3.96M
4
WCC
WESCO International
WCC
+$3.55M
5
IDTI
Integrated Device Technology I
IDTI
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.58%
3 Industrials 10.71%
4 Consumer Staples 7.92%
5 Materials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLXS icon
201
Flexsteel Industries
FLXS
$306M
– –
-10,708
Closed -$543K
IART icon
202
Integra LifeSciences
IART
$1.54B
– –
-4,000
Closed -$202K
INTU icon
203
Intuit
INTU
$81.1B
– –
-4,144
Closed -$589K
IPG
204
DELISTED
Interpublic Group of Companies
IPG
– –
-29,326
Closed -$610K
NATH icon
205
Nathan's Famous
NATH
$402M
– –
-7,550
Closed -$558K
NUE icon
206
Nucor
NUE
$56.4B
– –
-8,387
Closed -$470K
OPK icon
207
Opko Health
OPK
$921M
– –
-13,000
Closed -$89K
PARA
208
DELISTED
Paramount Global Class B
PARA
– –
-10,624
Closed -$616K
PATK icon
209
Patrick Industries
PATK
$2.8B
– –
-36,934
Closed -$1.38M
PBH icon
210
Prestige Consumer Healthcare
PBH
$2.35B
– –
-65,499
Closed -$3.28M
PRGS icon
211
Progress Software
PRGS
$1.55B
– –
-21,293
Closed -$813K
RF icon
212
Regions Financial
RF
$26.3B
– –
-37,717
Closed -$574K
SJM icon
213
J.M. Smucker
SJM
$12.6B
– –
-5,837
Closed -$612K
SXT icon
214
Sensient Technologies
SXT
$5.4B
– –
-2,667
Closed -$205K
TSCO icon
215
Tractor Supply
TSCO
$16.3B
– –
-350,790
Closed -$4.44M
TWLO icon
216
Twilio
TWLO
$29.1B
– –
-24,234
Closed -$723K
WCC
217
WESCO International
WCC
$16.2B
– –
-60,927
Closed -$3.55M
SGEN
218
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-3,940
Closed -$214K
NUVA
219
DELISTED
NuVasive, Inc.
NUVA
– –
-10,714
Closed -$594K
TEN
220
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
– –
-80,814
Closed -$4.9M
BSTC
221
DELISTED
BioSpecifics Technologies Corp.
BSTC
– –
-6,190
Closed -$288K
CBM
222
DELISTED
Cambrex Corporation
CBM
– –
-19,710
Closed -$1.08M
IDTI
223
DELISTED
Integrated Device Technology I
IDTI
– –
-126,349
Closed -$3.36M
SCG
224
DELISTED
Scana
SCG
– –
-8,690
Closed -$421K
MULE
225
DELISTED
MuleSoft, Inc.
MULE
– –
-32,519
Closed -$655K
6 7 8
9
10

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2017 Portfolio in Review

As of Q4 2017, Stanley-Laman Group held 310 positions worth $463M, up 24% from $375M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group deployed $76.3M of net new capital in Q4 2017, opening 106 new positions and adding to 69 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JBT Marel, an estimated $889K trimmed.

  • Stanley-Laman Group's largest Q4 2017 buy was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.
  • Stanley-Laman Group added most to Proofpoint, Inc. in Q4 2017, an estimated $5.74M increase.
  • Stanley-Laman Group's biggest Q4 2017 reduction was JBT Marel, cutting an estimated $889K.
  • Stanley-Laman Group fully exited Tenneco Inc. Class A Voting Common Stock in Q4 2017, selling an estimated $4.9M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $463M portfolio in Q4 2017.
  • Stanley-Laman Group opened 106 new positions and closed 41 in Q4 2017.
  • Stanley-Laman Group's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.